Ss Innovations International Inc. · NASDAQ:SSII
Ss Innovations International — Investor Presentation (June 2026)
28 slides from Ss Innovations International's investor presentation, June 2026
Slide 1: We Build Advanced, Affordable and Accessible Surgical Robotic Solutions
We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation June 2026 Nasdaq: SSII
Slide 2: Disclaimers
Disclaimers No Offering of Securities No offer is made by this Company Presentation (this “Presentation”) to invest in SS Innovations International, Inc. (the “Company”) or to purchase any of its securities. Any offer to make such an investment or purchase and such investment or purchase will be mad
Slide 3: Our Vision
Our Vision To continuously improve and deploy our technologically- advanced, cost-effective surgical robotic systems, while maintaining affordability and accessibility for the benefit of a larger segment of patients globally © 2026 SS INNOVATIONS INTERNATIONAL, INC. 3
Slide 4: Snapshot of SS Innovations
Snapshot of SS Innovations • We develop innovative, differentiated surgical robotic technologies, highlighted by our: 11,270 210 Multi-Specialty Surgeries SSI Mantra Systems Installed • Proprietary surgical robotic system, the SSi Mantra 3; • Comprehensive suite of surgical instruments, which 9 186
Slide 5: Snapshot of SS Innovations (Continued)
Snapshot of SS Innovations (Continued) Headquarters Gurugram, India Head & Neck Thoracic Company Domicile Florida, USA Gastrointestinal 125 105 Breast and Employees (May 31, 2026) 479 287 Plastic 11 Year Merged with Avra Medical 2023 Year Uplisted to Nasdaq 2025 Ticker SSII Cardiac 587 Exchange Nasd
Slide 6: Investment Highlights
Investment Highlights 1• Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology 2• Large and Growing Total Addressable Market with Favorable Industry Tailwinds 3• Advanced, Cost-Efficient Surgical Robotics Platform – Clinically and Commercially Differentiated 4•
Slide 7: Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology
Distinguished Leadership and Board with Proven Track Record in Surgical Robotics Technology Sudhir Srivastava, MD, Founder, Chairman & CEO Barry Cohen, COO – Americas & Board Member • Robotic cardiac surgeon with 40+ years of experience • Co-Founder, CEO and Director, Avra Medical Robotics • Pioneer
Slide 8: Accelerated Global Adoption of Robotic Surgery
Large and Growing Addressable Market with Favorable Industry Tailwinds Accelerated Global Adoption of Robotic Surgery Key Market Trends Global Surgical Robotics Market (in USD billions)1 Innovation and enhanced capabilities make next-generation systems Technology versatile across a broad spectrum of
Slide 9: Access to Robotic Surgery Remains Limited
Large and Growing Addressable Market with Favorable Industry Tailwinds Access to Robotic Surgery Remains Limited Benefits of Robotic Surgery Reduced Smaller Greater Minimal Blood Faster 10x Magnified Less Pain and Reduced Risk Surgeon Incisions on Precision Loss Recovery 3D vision Discomfort of Infe
Slide 10: Unmet Needs and Market Opportunity Support Our Foundational Market in India
Large and Growing Addressable Market with Favorable Industry Tailwinds Unmet Needs and Market Opportunity Support Our Foundational Market in India 1.5 Hospital Beds Estimated need of 5,000 ~1.4 Billion ~70,000 per 1,000 people surgeries per year per Population Hospitals (compared to the 100,000 peop
Slide 11: SSi Mantra 3
Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 2 2 Patient-Side Robotic Arm Carts 3 Vision Cart 3 Modular robotic arms mounted on individual carts with the option of 3D 4K resolution monitor, identical using 3, 4 or 5 robotic arm to the surgeon’s console, for OR configurations staf
Slide 12: SSi Mantra 3 – Surgical Command Center
Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 – Surgical Command Center Ergonomic Open-Faced Large 3D 4K Monitor Console Large 2D Touch Monitor Lightweight Magnetic for System Controls and Hand Controls Design DICOM access Head Tracking Digital Ergonomics Safety Feature Control Te
Slide 13: SSi Mantra 3 – Patient Side Robotic Arm Carts
Advanced, Cost-Efficient Surgical Robotics Platform SSi Mantra 3 – Patient Side Robotic Arm Carts Modular Freedom of Robotic Carts Patient Docking 3/4/5 Absolute Stability Patient Cart Parking Locks Connectivity Smaller Individual Advanced Touch Cart Footprint Screen Controls © 2026 SS INNOVATIONS I
Slide 14: SSi Mudra – Multi Specialty Robotic Instruments
Advanced, Cost-Efficient Surgical Robotics Platform SSi Mudra – Multi Specialty Robotic Instruments 20+ 1 1 40+ 7 Degrees of Freedom 10 Use Cardiac Specialty Instruments Types of Articulating Robotic Life Cycle Only company in the world actively advocating for robotic cardiac surgery Instruments Ins
Slide 15: SSi Maya – Enhancing Surgical Capabilities with Mixed Reality and AI Enabled Technologies
Advanced, Cost-Efficient Surgical Robotics Platform SSi Maya – Enhancing Surgical Capabilities with Mixed Reality and AI Enabled Technologies SSi Guru AR Smart Glasses1 Cognitive Skill Simulator1 XR Tele Proctoring System 3D Visualization System A different approach to train surgeons • Mixed Reality
Slide 16: Pioneering Telesurgery Capabilities and Mobile Robotic Telesurgery Unit
Advanced, Cost-Efficient Surgical Robotics Platform Pioneering Telesurgery Capabilities and Mobile Robotic Telesurgery Unit 171 telesurgeries have been completed with the SSi Mantra surgical robotic system2 Mar 2025 SSII HQ Aster CMI Hospital 1,245 miles Gurugram, India Bengaluru, India Jul 2025 IRC
Slide 17: The SSi MantrAsana Tele-Surgeon Console
Advanced, Cost-Efficient Surgical Robotics Platform The SSi MantrAsana Tele-Surgeon Console Facilitates Telesurgery from “Anywhere” SSi MantrAsana Tele-Surgeon Console Compact Self- Contained Chair Enables Portability Inbuilt Electronics Requires Less Space Magnetic Sensor- Based Controls Facilitate
Slide 18: World-Class R&D and Manufacturing Facilities to Support Growth and Cost Efficiency
Established Presence in India with Global Expansion Underway World-Class R&D and Manufacturing Facilities to Support Growth and Cost Efficiency Proximity to R&D, Manufacturing, New Delhi Assembly, and Operations International airport in Gurgaon, Delhi with excellent National Capital Region connectiv
Slide 19: SSi Mantra 3 Is Demonstrating Rapid Adoption Across Various Geographies
Established Presence in India with Global Expansion Underway SSi Mantra 3 Is Demonstrating Rapid Adoption Across Various Geographies Overview of Installed Base Cumulative Installed Base +149% 210 194 as of May 31, 2026 78 As of 3/31/25 As of 3/31/26 Completed Procedures +173% 9,744 11,270 as of May
Slide 20: Global Expansion - Regulatory Approvals
Established Presence in India with Global Expansion Underway Global Expansion - Regulatory Approvals India CDSCO Guatemala Indonesia Ecuador 2023 2023 2024 2024 Philippines Ukraine UAE Colombia 2025 2025 2025 2025 Oman Iraq Sri Lanka Kenya 2025 2025 2026 2026 Nepal Guyana US FDA EU CE 2026 2026 Anti
Slide 21: Estimated Regulatory Timelines
Established Presence in India with Global Expansion Underway Estimated Regulatory Timelines Current Stage US FDA FDA Q Sub Regulatory Strategy 510(k) 510(k) Submitted for File Under FDA Review / Feedback, Biocompatibility, Technical dossier Multi-Specialty Indications Review Market Clearance Reproce
Slide 22: Strong Sales Growth with an Increasing Mix of Recurring Consumables Revenue and Expanding Margins
Strong Sales Growth with an Increasing Mix of Recurring Consumables Revenue and Expanding Margins Revenue Revenue Mix Gross Margin ($ millions) (%) (%) +106% +507 bps $42.5 +2,858 bps 46.00% 40.93% +251% $42.5 mm $20.6 85% Revenue 15% 2025 12.35% $5.9 2023 2024 2025 2023 2024 2025 1 Systems Capital
Slide 23: First Quarter 2026 – Robust Growth in Revenue and SSi Mantra Installations and Procedures
First Quarter 2026 – Robust Growth in Revenue and SSi Mantra Installations and Procedures Revenue SSi Mantra Installations SSi Mantra Procedures ($ millions) (# of systems) (# of surgeries) +117% +73% +136% $11.1 1,859 26 15 $5.1 787 Q1'25 Q1'26 Q1'25 Q1'26 Q1'25 Q1'26 © 2026 SS INNOVATIONS INTERNAT
Slide 24: Growth Strategy
Growth Strategy Target Leading Surgeons and Thought Platform Focus on Large Leaders to Raise Awareness and Value Multi-Specialty Hospitals Encourage Widespread Adoption • Advanced Technology • Secure Initial Placements • Indian Medical Advisory Board • Lower Cost • Expand # of Physicians using Mantr
Slide 25: Appendix
Appendix © 2026 SS INNOVATIONS INTERNATIONAL, INC. 25
Slide 26: FY 2023 – FY 2025 Financial Summary
FY 2023 – FY 2025 Financial Summary SS Innovations Twelve Months Ended Three Months Ended Statement of Operations (in USD) Dec. 31, 2023 Dec. 31, 2024 Dec. 31, 2025 March 31, 2025 March 31, 2026 Revenue 5,875,314 20,649,528 42,484,747 5,120,610 11,101,366 Gross Profit 725,528 8,452,366 19,544,255 1,
Slide 27: Summary of SSi Mantra Installations
Summary of SSi Mantra Installations Annual Installations Quarterly Installations Year # Growth Year # Growth 103 Q1’24 9 - 2022 3 - Q2’24 10 - 2023 15 400% 47 Q3’24 6 - 2024 47 213% 15 3 Q4’24 22 - 38 2025 103 119% 2022 2023 2024 2025 Q1’25 15 67% Q2’25 23 130% Q3’25 27 350% 27 26 Q4’25 38 73% 23 22
Slide 28: Investor Contact
Investor Contact: Kalle Ahl, CFA (303) 953-9878 kalle.ahl@theequitygroup.com www.ssinnovations.com investors@ssinnovations.org © 2026 SS INNOVATIONS INTERNATIONAL, INC. 28
SS Innovations International — Investor Presentation (June 2026) on 6ix